Refractory pleural effusion in malignant hypertension leading to an unexpected diagnosis of tuberculosis: A case report
Related Experiment Video
Updated: Jan 15, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Hiroki Ito1, Kentaro Yano1, Yuya Suzuki1
1Division of Nephrology and Hypertension, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 983-8536, Japan.
Abstract:
Accelerated malignant hypertension frequently manifests as multiple organ dysfunctions. However, persistent symptoms despite appropriate antihypertensive therapy warrant investigation of concurrent pathologies, particularly in patients with risk factors for opportunistic infections. A 57-year-old woman with untreated hypertension presented in August 2024, with markedly elevated blood pressure (208/122 mmHg), systolic dysfunction (ejection fraction, 42.5%) and acute kidney injury (creatinine 4.74 mg/dl). Accelerated malignant hypertension with multiple organ damage was diagnosed based on these findings. Despite optimal antihypertensive and diuretic therapy, pleural effusion and renal function progressively worsened. Thoracentesis revealed a lymphocyte-predominant exudative effusion with elevated adenosine deaminase levels. Subsequent investigations confirmed tuberculous pleuritis and peritonitis, ultimately diagnosed as miliary tuberculosis. Excessive diuretic therapy for presumed heart failure-related effusion exacerbates renal injury. Following initiation of antituberculous therapy, pleural effusion and renal function markedly improved. This case emphasizes the importance of reevaluating initial diagnoses when the clinical responses are suboptimal. In patients with multiple risk factors, particularly diabetes mellitus and kidney dysfunction, concurrent tuberculosis should be considered for treatment-refractory symptoms.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...

